Back to search
SLC13A5 Citrate Transporter Disorder
Clinical trial pipeline · Data from ClinicalTrials.gov
See which SLC13A5 Citrate Transporter Disorder trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which SLC13A5 Citrate Transporter Disorder trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Phase 1/2, open-label study to assess the efficacy and safety of a single lumbar intrathecal administration of TSHA-105 in individuals with SLC13A5 Citrate Tran…
SLC13A5 deficiency (Citrate Transporter Disorder, EIEE 25) is a rare genetic disorder with neurodevelopmental delays and seizure onset in the first few days of…
SLC13A5 deficiency (Citrate Transporter Disorder, EIEE 25) is a rare genetic disorder with neurodevelopmental delays and seizure onset in the first few days of…